Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches
Planta Medica · 01.08.2024 · 90 (10) · 801-809
DOI: 10.1055/a-2339-2720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2024. Verfasst von Xing Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Lab of Traditional Chinese Medicine Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical Universit…. Hauptthemen laut MEDLINE: Panax notoginseng, Molecular Docking Simulation, Thrombin, Molecular Dynamics Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Thrombin is a crucial enzyme in the coagulation cascade, and inhibitors of thrombin have been extensively studied as potential antithrombotic agents. The objective of this study was to identify natural inhibitors of thrombin from Panax notoginseng and evaluate their biological activity in vitro and binding characteristics. A combined approach involving molecular docking, thrombin inhibition assays, surface plasmon resonance, and molecular dynamics simulation was utilized to identify natural thrombin inhibitors. The results demonstrated that panaxatriol directly inhibits thrombin, with an IC50 of 10.3 µM. Binding studies using surface plasmon resonance revealed that panaxatriol interacts with thrombin, with a KD value of 7.8 µM. Molecular dynamics analysis indicated that the thrombin-panaxatriol system reached equilibrium rapidly with minimal fluctuations, and the calculated binding free energy was − 23.8 kcal/mol. The interaction between panaxatriol and thrombin involves the amino acid residues Glu146, Glu192, Gly216, Gly219, Tyr60A, and Trp60D. This interaction provides a mechanistic basis for further optimizing panaxatriol as a thrombin inhibitor. Our study has shown that panaxatriol serves as a direct thrombin inhibitor, laying the groundwork for further research and development of novel thrombin inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Key Lab of Traditional Chinese Medicine Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- Pharmacy Department, The 989th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Luoyang, China.
- Key Laboratory of Ethnomedicine (Ministry of Education), School of Pharmacy, Minzu University of China, Beijing, China.
ORCID-Profile: Xing Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Ma, Y., Zuo, C., Zhao, Z., Ma, R., Wang, L., Fang, Y., Zhang, Y., & Wu, X. (2024). Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches. Planta Medica, 90(10), 801-809. https://doi.org/10.1055/a-2339-2720
Vancouver
Wang X, Ma Y, Zuo C, Zhao Z, Ma R, Wang L, et al. Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches. Planta Medica. 2024;90(10):801-809. doi:10.1055/a-2339-2720
BibTeX
@article{Wang2024,
author = {Wang, Xing and Ma, Yuqing and Zuo, Chunfang and Zhao, Zixi and Ma, Ruonan and Wang, Lele and Fang, Yuzhen and Zhang, Yuxin and Wu, Xia},
title = {Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {10},
pages = {801--809},
doi = {10.1055/a-2339-2720}
}
EUVIMED